Literature DB >> 9283567

Acute and chronic animal models for excessive dermal scarring: quantitative studies.

D E Morris1, L Wu, L L Zhao, L Bolton, S I Roth, D A Ladin, T A Mustoe.   

Abstract

Excessive scarring in the form of keloids and hypertrophic scars continues to be a clinical problem for some patients. The lack of an animal model for such scarring has been an obstacle to studying the cellular and molecular biology of these entities. Previous observations made by the authors that some surgical scars in the rabbit ear remain raised for months after wounding prompted us to investigate whether the rabbit ear might provide a model by which to study excessive dermal scarring. After establishing the model in preliminary study, 40 excisional wounds, 6 mm in diameter, were created over the ventral surface of rabbit ears. Elevated scars were treated with either intralesional triamcinolone acetonide or saline at day 16 postwounding. On day 22, 25 scar wounds were used for thorough histomorphometric analysis, 15 wounds were eliminated prior to analysis because of invagination of epithelial tissue, which made analysis difficult. Total area of scar and Hypertrophic Index, a ratio comparing scar prominence with the thickness of adjacent unwounded tissue, were measured for 25 (62 percent) of the resulting scars. Both total area of scar and Hypertrophic Index were found to be significantly decreased in the steroid-treated group (p < 0.02 and < 0.03, respectively). In a chronic form of this model, in which larger excisions were taken, an excessive accumulation of both new collagen and cartilage over 9 months was observed. An animal model for excessive dermal scarring that allows quantitation of scar formation and, at an early stage, can be modulated in a predictable way with intralesional corticosteroid treatment is presented. This model may parallel hypertrophic scarring in humans and thus might provide a tool by which to study its pathophysiology and objectively evaluate therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283567     DOI: 10.1097/00006534-199709000-00021

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  65 in total

Review 1.  The Northwestern Abdominoplasty Scar Model: A Tool for High-Throughput Assessment of Scar Therapeutics.

Authors:  Ji-Cheng Hsieh; Chitang J Joshi; Rou Wan; Robert D Galiano
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-29       Impact factor: 4.730

2.  Recombinant human endostatin reduces hypertrophic scar formation in rabbit ear model through down-regulation of VEGF and TIMP-1.

Authors:  Peng Wang; Li-Zhu Jiang; Bin Xue
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

3.  The role of Th1/Th2 cell chemokine expression in hypertrophic scar.

Authors:  Baoguo Chen; Huichao Li; Wei Xia
Journal:  Int Wound J       Date:  2019-11-05       Impact factor: 3.315

4.  Imiquimod regulating Th1 and Th2 cell-related chemokines to inhibit scar hyperplasia.

Authors:  Baoguo Chen; Huichao Li; Wei Xia
Journal:  Int Wound J       Date:  2019-09-02       Impact factor: 3.315

5.  Survival of human cadaver skin on severe combined immune deficiency pigs: Proof of concept.

Authors:  Adam J Singer; Christopher Tuggle; Amanda Ahrens; Mary Sauer; Steve A McClain; Edward Tredget; Lior Rosenberg
Journal:  Wound Repair Regen       Date:  2019-03-19       Impact factor: 3.617

6.  In Vivo Evaluation of Three-Dimensional Printed, Keratin-Based Hydrogels in a Porcine Thermal Burn Model.

Authors:  Javier Navarro; Ryan M Clohessy; Robert C Holder; Alexis R Gabard; Gregory J Herendeen; Robert J Christy; Luke R Burnett; John P Fisher
Journal:  Tissue Eng Part A       Date:  2020-01-09       Impact factor: 3.845

7.  Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study.

Authors:  Maday Fernández-Mayola; Lázaro Betancourt; Alicia Molina-Kautzman; Sucel Palomares; Yssel Mendoza-Marí; Dayana Ugarte-Moreno; Ana Aguilera-Barreto; Yilian Bermúdez-Álvarez; Vladimir Besada; Luis J González; Ariana García-Ojalvo; Ana J Mir-Benítez; Aleida Urquiza-Rodríguez; Jorge Berlanga-Acosta
Journal:  Int Wound J       Date:  2018-02-21       Impact factor: 3.315

8.  Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?

Authors:  Inês Correia-Sá; Paula Serrão; Marisa Marques; Maria A Vieira-Coelho
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

9.  Expression of collagen genes in the cones of skin in the Duroc/Yorkshire porcine model of fibroproliferative scarring.

Authors:  Kathy Q Zhu; Gretchen J Carrougher; Oliver P Couture; Christopher K Tuggle; Nicole S Gibran; Loren H Engrav
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

10.  A Novel Nude Mouse Model of Hypertrophic Scarring Using Scratched Full Thickness Human Skin Grafts.

Authors:  Saad M Alrobaiea; Jie Ding; Zengshuan Ma; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-07-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.